Chinese Expert Consensus on Application of HPV Vaccine in Perioperative Treatment of High-Grade Cervical Intraepithelial Neoplasia (2025 Edition)

• Published in: Zhongliu fangzhi yanjiu Vol. 52; no. 3; pp. 177 - 184
• Main Author: Cervical Cancer Prevention and Control Research Professional Committee of Chinese Association for Maternal and Child Health Study
• Format: Journal Article
• Language: Chinese; English
• Published: Tianjin China Anti-Cancer Association 2025; Magazine House of Cancer Research on Prevention and Treatment
• Subjects: Cervical cancer; consensus; Guidelines; high-grade squamous intraepithelial lesion; hpv vaccine; Human papillomavirus; Immunization; recurrence; resection treatment; Risk reduction; Vaccines; China

In women with high-grade squamous intraepithelial lesion (HSIL) undergoing excision therapy, vaccination with human papillomavirus (HPV) vaccine may reduce the risk of postoperative recurrence. However, research data and clear application guidelines are currently limited in China. The Cervical Cance...